Posterity Health, a male reproductive health-focused startup, has raised $6 million in the latest round to scale business operations and accelerate the development of its tech-backed care platform.
As the company announced on Wednesday, May 29, 2024, the round was led by FCA Venture Partners, a Nashville-based venture capital firm, with the participation of Distributed Ventures and WVV.
Posterity will use the additional funds to expand its executive team, speed up the development of its tech-backed software platform, Male Management Platform (MMP), and launch new services on the market.
Posterity Health’s platform leverages innovative technology, AI-driven protocols, and expert care teams to drive personalized end-to-end male care. The platform is also designed to facilitate efficient access, allowing the company to scale rapidly and provide seamless access to more males. This allows Posterity Health to contact 99% of the male patients on the same day of receiving their referral and meet 75% of the patients within two weeks.
The platform employs a hybrid care delivery model, combining in-person care with telehealth appointments to ensure continuity of care. The approach also includes AI modules and data analytics to utilize the data collected effectively to enable real-time research, providing more insights into male fertility treatment and care.
With the company looking to grow, the new funding will also help to expand its services beyond male fertility to offer a full suite of reproductive services, such as Low-T services.